Clinical Diabetology最新文献

筛选
英文 中文
Association of Bone Turnover Biomarkers and Subclinical Atherosclerosis in Subjects with Type 2 Diabetes: A Case-Control Study 2 型糖尿病患者骨转换生物标志物与亚临床动脉粥样硬化的关系:病例对照研究
IF 0.7
Clinical Diabetology Pub Date : 2024-03-01 DOI: 10.5603/cd.98236
N. Lachine, Eman Y. Morsy, A. Elnekiedy, Mohamed A. Sadaka, G. I. Khalil, Hesham G. Imam, H. Kassab, Noha G. Amin
{"title":"Association of Bone Turnover Biomarkers and Subclinical Atherosclerosis in Subjects with Type 2 Diabetes: A Case-Control Study","authors":"N. Lachine, Eman Y. Morsy, A. Elnekiedy, Mohamed A. Sadaka, G. I. Khalil, Hesham G. Imam, H. Kassab, Noha G. Amin","doi":"10.5603/cd.98236","DOIUrl":"https://doi.org/10.5603/cd.98236","url":null,"abstract":"Objective: The current study aims to assess the relationship between serum osteocalcin (OCN) and osteoprotegerin (OPG) levels and subclinical atherosclerosis. Material and methods: This case-control study included 80 male subjects divided into 2 groups: 40 subjects with type 2 diabetes (T2D) without coronary artery disease and 40 control subjects without diabetes. To assess the association of OCN and OPG with subclinical atherosclerosis (defined as carotid intima-media thick - ness (cIMT) ≥ 0.9mm), multivariable linear regression models were applied. Results: The mean age in the diabetes group was 54.1 ± ± 5.1 years while in the control group, it was 53.7 ± ± 6.6 years. The mean serum OCN level was signifi - cantly negatively correlated with hs-CRP, cIMT, HbA1c and FPG in the total sample (p = 0.001, < 0.001, < 0.001 and 0.006 respectively) while OPG level was significantly positively correlated with age and HbA1c (p = 0.047 and 0.009 respectively) in the total sample. Age and HbA1c were the only independent risk factors identifying subclinical atherosclerosis in multivariate analysis. A cut-off value of serum OCN level of ≤ 22 ng/mL was able to discriminate patients with subclinical atherosclerosis in the total sample (p = 0.003 * ) using receiver operator characteristic (ROC) curve analysis. Serum OCN level was significantly lower in the subclini - cal atherosclerosis group than in the control while OPG showed no significant difference between both groups. Conclusions: OCN may be a better marker for subclinical atherosclerosis than OPG. This effect is attenuated in the presence of DM. (Clin Diabetol 2024; 13, 1: 43–51)","PeriodicalId":10386,"journal":{"name":"Clinical Diabetology","volume":null,"pages":null},"PeriodicalIF":0.7,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140271566","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
'Clinical Diabetology': Highlights of 2023 and Future Direction 临床糖尿病学2023 年亮点与未来方向
IF 0.7
Clinical Diabetology Pub Date : 2024-03-01 DOI: 10.5603/cd.99403
Viral N. Shah, Łukasz Stolarczyk
{"title":"'Clinical Diabetology': Highlights of 2023 and Future Direction","authors":"Viral N. Shah, Łukasz Stolarczyk","doi":"10.5603/cd.99403","DOIUrl":"https://doi.org/10.5603/cd.99403","url":null,"abstract":"","PeriodicalId":10386,"journal":{"name":"Clinical Diabetology","volume":null,"pages":null},"PeriodicalIF":0.7,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140270168","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A Practical Approach to the Initiation, Titration and Intensification of Insulin Therapy in Adults with Diabetes in the Indian Context: Recommendations by Association of Clinical Endocrinologists Consensus Group 印度成人糖尿病患者胰岛素治疗的启动、剂量调整和强化的实用方法:临床内分泌医师协会共识小组的建议
IF 0.7
Clinical Diabetology Pub Date : 2024-03-01 DOI: 10.5603/cd.98136
R. Erukulapati, Manikandan R. M., Leenatha Reddy Jakkidi, S. Sathyanarayana, U. Ayyagari, Srinath Ashwathiah, S. Nalla, Satish Kumar Sampath, S. Manohar, Sanjay Shah, Chandan Kamath, Bhanu Praveen, M. Kushe, Radhika V. Kumar, Ravikumar Bachuwar, Murali Ganguri
{"title":"A Practical Approach to the Initiation, Titration and Intensification of Insulin Therapy in Adults with Diabetes in the Indian Context: Recommendations by Association of Clinical Endocrinologists Consensus Group","authors":"R. Erukulapati, Manikandan R. M., Leenatha Reddy Jakkidi, S. Sathyanarayana, U. Ayyagari, Srinath Ashwathiah, S. Nalla, Satish Kumar Sampath, S. Manohar, Sanjay Shah, Chandan Kamath, Bhanu Praveen, M. Kushe, Radhika V. Kumar, Ravikumar Bachuwar, Murali Ganguri","doi":"10.5603/cd.98136","DOIUrl":"https://doi.org/10.5603/cd.98136","url":null,"abstract":"guiding general physicians and general practitioners. Hence, this consensus statement uses the modified Delphi method. The Association of Clinical Endocrinologists is a non-profit, non-commercial body registered in India, that serves as a platform for like-minded Endocrinologists who aspire to work for the cause of the science of Diabetes and Endocrinology, its utility and application for the betterment of the health of the people and the country. The authors request the readers to please do not confuse this Association of Clinical Endocri - nologists with the American College of Endocrinology/ /American Association of Clinical Endocrinologists (ACE/AACE) of the United States of America (USA).","PeriodicalId":10386,"journal":{"name":"Clinical Diabetology","volume":null,"pages":null},"PeriodicalIF":0.7,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140272627","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Efficacy of Insulin Degludec/Insulin Aspart (IDegAsp) vs. Insulin Glargine (IGlarU300) in Insulin-Naïve Patients with Type 2 Diabetes: A Retrospective Study 对胰岛素无效的 2 型糖尿病患者使用胰岛素 Degludec/Insulin Aspart (IDegAsp) 与胰岛素 Glargine (IGlarU300) 的疗效:回顾性研究
IF 0.7
Clinical Diabetology Pub Date : 2024-03-01 DOI: 10.5603/cd.98892
D. Hasnani, Santosh Jha, B. Saboo, Pusala Lakshmi Prasanna, Ami Sanghvi, Alpana Sowani, V. Chavda
{"title":"Efficacy of Insulin Degludec/Insulin Aspart (IDegAsp) vs. Insulin Glargine (IGlarU300) in Insulin-Naïve Patients with Type 2 Diabetes: A Retrospective Study","authors":"D. Hasnani, Santosh Jha, B. Saboo, Pusala Lakshmi Prasanna, Ami Sanghvi, Alpana Sowani, V. Chavda","doi":"10.5603/cd.98892","DOIUrl":"https://doi.org/10.5603/cd.98892","url":null,"abstract":"","PeriodicalId":10386,"journal":{"name":"Clinical Diabetology","volume":null,"pages":null},"PeriodicalIF":0.7,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140275163","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Association between High-Sensitivity C-Reactive Protein and Metabolic Syndrome and Its Components in Older Adults: Findings from Neyshabur Longitudinal Study on Ageing (NeLSA) 老年人高敏 C-反应蛋白与代谢综合征及其组成部分之间的关系:内沙布尔老龄化纵向研究(NeLSA)的发现
IF 0.7
Clinical Diabetology Pub Date : 2024-03-01 DOI: 10.5603/cd.98280
A. Sahebkar, Peyman Habibi, Faeze Sadat Talebian, S. M. Haftcheshmeh, Fatemeh Abdollahi, Nazanin Fekri, T. Jamialahmadi, Željko Reiner, S. Mirhafez
{"title":"Association between High-Sensitivity C-Reactive Protein and Metabolic Syndrome and Its Components in Older Adults: Findings from Neyshabur Longitudinal Study on Ageing (NeLSA)","authors":"A. Sahebkar, Peyman Habibi, Faeze Sadat Talebian, S. M. Haftcheshmeh, Fatemeh Abdollahi, Nazanin Fekri, T. Jamialahmadi, Željko Reiner, S. Mirhafez","doi":"10.5603/cd.98280","DOIUrl":"https://doi.org/10.5603/cd.98280","url":null,"abstract":"Objective: To evaluate the association between high-sensitivity C-reactive protein (hsCRP) and metabolic syndrome (MetS), components of the MetS as well as diabetes, and cardiovascular complications. Materials and methods: In this cross-sectional analysis, the data were collected from the registration phase of Neyshabur Longitudinal Study on Ageing (NeLSA) comprising a total of 6034 people aged 50 and older. Association between hsCRP and MetS and its components was conducted by univariate and multivariate analyses in the presence of covariates and confounding factors. Results: Baseline data including age, body fat mass, body mass index, waist-to-hip ratio, fasting plasma glucose, triglyceride, creatinine, albumin, and hsCRP also systolic blood pressure, and diastolic blood pressure were higher in the MetS group compared to the control group (p < 0.001 for all variables other than hsCRP, which was not significant (p = 0.06)). Also the univariate and multi variate analysis illustrated one-unit increase in the serum level of hsCRP was associated with 18% higher risk for diabetes [OR: 1.18; 95% confidence interval (CI), 1.06–1.30] and increased high-density lipoprotein cholesterol (HDL-C) by 15% (OR:1.15; (95% CI, 1.01–1.29). In subjects with MetS, one-unit (log of 1 mg/L) increase in the serum level of hsCRP was associated with 34% higher risk for atherosclerotic cardiovascular disease (ASCVD) (OR: 1.34; 95% CI, 1.11–1.63). Conclusions: There is an association between serum level of hsCRP and the presence of the components of MetS including HDL-C and diabetes, especially in women. (Clin Diabetol 2024; 13, 1: 52–59)","PeriodicalId":10386,"journal":{"name":"Clinical Diabetology","volume":null,"pages":null},"PeriodicalIF":0.7,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140271681","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Type 2 Diabetes at a Military Health Centre in Brazil: Clinical and Pharmacotherapeutic Profile 巴西一家军事医疗中心的 2 型糖尿病患者:临床和药物治疗概况
IF 0.7
Clinical Diabetology Pub Date : 2024-03-01 DOI: 10.5603/cd.98362
André Henrique Freitas de Braga e Bessa, Julieta Ueta, V. D. Mayrink, R. Oliveira
{"title":"Type 2 Diabetes at a Military Health Centre in Brazil: Clinical and Pharmacotherapeutic Profile","authors":"André Henrique Freitas de Braga e Bessa, Julieta Ueta, V. D. Mayrink, R. Oliveira","doi":"10.5603/cd.98362","DOIUrl":"https://doi.org/10.5603/cd.98362","url":null,"abstract":"Objective: To analyze the clinical and pharmacothera-peutic profile of people with type 2 diabetes (T2D) at a military health center in Brazil. Materials and methods: This is a cross-sectional study. The sample of 170 medical records was selected by means of probabilistic sampling. The data collected were sociodemographic, clinical and laboratory data related to diabetes, as well as prescribed medications. Results: Most of the subjects were male (57.6%), elderly (64.7%) and inactive military (55.2%). Adequate gly - cemic control was observed in 75.9% of the subjects, which was positively associated with multimorbidity and mono-therapeutic treatment (p < 0.05). Negative associations were observed in those subjects attend - ing medical appointments less frequently and using prescribed insulin (p < 0.05). Medications prescribed for treatment of T2D were the following: metformin (90.6%), sulfonylureas (22.9%), dipeptidyl peptidase in - hibitors-4 (16.5%) and sodium-glucose 2 co-transporter inhibitors (10.0%), in which 50.6% were monotherapy. Multimorbidity was 97.6%, in which systemic arte - rial hypertension (71.8%), lipid disorders (65.9%) and cardiovascular diseases (26.5%) were the main clinical conditions.","PeriodicalId":10386,"journal":{"name":"Clinical Diabetology","volume":null,"pages":null},"PeriodicalIF":0.7,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140281046","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
SGLT2 Inhibitor Significantly Improved Plasma Glucose Levels in a Patient with Latent Autoimmune Diabetes of Adults: A Case Report SGLT2 抑制剂显著改善了一名成人潜伏性自身免疫性糖尿病患者的血浆葡萄糖水平:病例报告
IF 0.7
Clinical Diabetology Pub Date : 2024-03-01 DOI: 10.5603/cd.99034
S. Okada, Kazuya Okada, Junichi Okada, Eijiro Yamada, Kumeo Ono
{"title":"SGLT2 Inhibitor Significantly Improved Plasma Glucose Levels in a Patient with Latent Autoimmune Diabetes of Adults: A Case Report","authors":"S. Okada, Kazuya Okada, Junichi Okada, Eijiro Yamada, Kumeo Ono","doi":"10.5603/cd.99034","DOIUrl":"https://doi.org/10.5603/cd.99034","url":null,"abstract":"","PeriodicalId":10386,"journal":{"name":"Clinical Diabetology","volume":null,"pages":null},"PeriodicalIF":0.7,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140086513","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Dotting the I’s and Crossing the T’s of Insulin Therapy in India 印度胰岛素治疗的 "点 "与 "线
IF 0.7
Clinical Diabetology Pub Date : 2024-03-01 DOI: 10.5603/cd.99116
Om J Lakhani
{"title":"Dotting the I’s and Crossing the T’s of Insulin Therapy in India","authors":"Om J Lakhani","doi":"10.5603/cd.99116","DOIUrl":"https://doi.org/10.5603/cd.99116","url":null,"abstract":"","PeriodicalId":10386,"journal":{"name":"Clinical Diabetology","volume":null,"pages":null},"PeriodicalIF":0.7,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140275346","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Prevalence of Gastrointestinal Symptoms among Individuals with and without Diabetes: A Cross-Sectional Study from the PERSIAN Guilan Cohort Study 糖尿病患者和非糖尿病患者的胃肠道症状流行率:来自 PERSIAN 吉兰队列研究的横断面研究
IF 0.7
Clinical Diabetology Pub Date : 2023-12-22 DOI: 10.5603/cd.96670
Matin Mojaveri Samak, F. Joukar, S. Maroufizadeh, Soheil Hassanipour, Zahra Abbasi Ranjbar, S. Yeganeh, Elahe Abbaspour, M. Aleali, F. Mansour-Ghanaei
{"title":"Prevalence of Gastrointestinal Symptoms among Individuals with and without Diabetes: A Cross-Sectional Study from the PERSIAN Guilan Cohort Study","authors":"Matin Mojaveri Samak, F. Joukar, S. Maroufizadeh, Soheil Hassanipour, Zahra Abbasi Ranjbar, S. Yeganeh, Elahe Abbaspour, M. Aleali, F. Mansour-Ghanaei","doi":"10.5603/cd.96670","DOIUrl":"https://doi.org/10.5603/cd.96670","url":null,"abstract":"","PeriodicalId":10386,"journal":{"name":"Clinical Diabetology","volume":null,"pages":null},"PeriodicalIF":0.7,"publicationDate":"2023-12-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138944676","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Perceived Loneliness in Children with and without Type 1 Diabetes: A Cross-Sectional Study 1 型糖尿病患儿和非 1 型糖尿病患儿的孤独感:一项横断面研究
IF 0.7
Clinical Diabetology Pub Date : 2023-12-22 DOI: 10.5603/cd.96600
E. Kobos, Alicja Szewczyk, Beata Dziedzic
{"title":"Perceived Loneliness in Children with and without Type 1 Diabetes: A Cross-Sectional Study","authors":"E. Kobos, Alicja Szewczyk, Beata Dziedzic","doi":"10.5603/cd.96600","DOIUrl":"https://doi.org/10.5603/cd.96600","url":null,"abstract":"","PeriodicalId":10386,"journal":{"name":"Clinical Diabetology","volume":null,"pages":null},"PeriodicalIF":0.7,"publicationDate":"2023-12-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139166197","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信